 |
인쇄하기
취소
|
Boryung to export new antihypertensive agent to Brazil
Boryung Pharmaceutical Co. today said it has signed an exclusive distribution agreement with Brazil’s largest drugmaker Ache Pharmaceutical, who will take care of commercializing Boryung’s new antihypertensive drug Kanarb (fimasartan).
Under the agreement, Boryung will deliver Kanrb, worth $40 million, to Ase over the next five years.
Boryung will also receive upfront and milestone paymen...
Under the agreement, Boryung will deliver Kanrb, worth $40 million, to Ase over the next five years.
Boryung will also receive upfront and milestone paymen...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.